Cwa Asset Management Group, LLC Gilead Sciences, Inc. Transaction History
Cwa Asset Management Group, LLC
- $2.27 Billion
- Q2 2025
A detailed history of Cwa Asset Management Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 65,743 shares of GILD stock, worth $7.41 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
65,743
Previous 115,575
43.12%
Holding current value
$7.41 Million
Previous $13 Million
43.72%
% of portfolio
0.32%
Previous 0.63%
Shares
32 transactions
Others Institutions Holding GILD
# of Institutions
2,330Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.67 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.22 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.23 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $141B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...